North America Sepsis Diagnostics Market Size & Outlook
- Clinical Diagnostics
- In Vitro Diagnostics
- Sepsis Diagnostics Market Outlook
- In Vitro Diagnostics
Global Market
Related Markets
Ask Prism AI about the sepsis diagnostics market
Get cited answers from GVR research on market growth, segments, regulations and forecasts.
- Source-linked answers
- Market-specific context
- Traceable figures
North America sepsis diagnostics market highlights
- The North America sepsis diagnostics market generated a revenue of USD 547.2 million in 2025.
- The market is expected to grow at a CAGR of 7.8% from 2026 to 2033.
- In terms of segment, conventional diagnostics was the largest revenue generating method in 2025.
- Automated Diagnostics is the most lucrative method segment registering the fastest growth during the forecast period.
- Country-wise, Mexico is expected to register the highest CAGR from 2026 to 2033.
North America data book summary
| Market revenue in 2025 | USD 547.2 million |
| Market revenue in 2033 | USD 991.5 million |
| Growth rate | 7.8% (CAGR from 2026 to 2033) |
| Largest segment | Conventional diagnostics |
| Fastest growing segment | Automated Diagnostics |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Automated Diagnostics, Conventional Diagnostics |
| Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Other key industry trends
- In terms of revenue, North America region accounted for 44.4% of the global sepsis diagnostics market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 555.0 million by 2033.
North America held the largest share of 44.1% in 2023 and is expected to maintain this position over the forecast period. This can be attributed to the well-established healthcare infrastructure, which has led to an increase in the adoption of advanced sepsis diagnostic solutions in the region.
Furthermore, high incidence of sepsis is expected to fuel demand for novel sepsis diagnostic solutions. According to the data published by CDC in March 2024, one in three Americans who died in the hospital had sepsis during hospitalization.
This led to the high demand for rapid & accurate diagnosis and increased the adoption of point-of-care testing. Moreover, the rise in the geriatric population, increase in investments for research & development, and availability of favorable reimbursement policies are expected to drive the market.
No credit card required*
Publish Date: Jun 10, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sepsis Diagnostics Market Scope
Sepsis Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Roche Holding AG ADR | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Koninklijke Philips NV | View profile | 73,712 | Philips Center, Amstelplein 2, Amsterdam, Netherlands, 1096 BC | www.philips.com |
| BioMerieux SA | View profile | 13,982 | Marcy l’Etoile, Lyon, France, 69280 | www.biomerieux.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Bruker Corp | View profile | 9,707 | 40 Manning Road, Billerica, MA, United States, 01821 | www.bruker.com |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | www.bd.com |
| Luminex | View profile | 501-1000 | Austin, Texas, United States, North America | www.luminexcorp.com |
| Cepheid | View profile | 1001-5000 | Sunnyvale, California, United States, North America | www.cepheid.com |
| Immunexpress | View profile | 11-50 | Seattle, Washington, United States, North America | www.immunexpress.com |
North America Sepsis Diagnostics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Sepsis Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Conventional Diagnostics was the largest segment with a revenue share of 61.86% in 2025.
Horizon Databook has segmented the North America sepsis diagnostics market based on automated diagnostics, conventional diagnostics covering the revenue growth of each sub-segment from 2021 to 2033.
North America held the largest share of 44.1% in 2023 and is expected to maintain this position over the forecast period. This can be attributed to the well-established healthcare infrastructure, which has led to an increase in the adoption of advanced sepsis diagnostic solutions in the region.
Furthermore, high incidence of sepsis is expected to fuel demand for novel sepsis diagnostic solutions. According to the data published by CDC in March 2024, one in three Americans who died in the hospital had sepsis during hospitalization.
This led to the high demand for rapid & accurate diagnosis and increased the adoption of point-of-care testing. Moreover, the rise in the geriatric population, increase in investments for research & development, and availability of favorable reimbursement policies are expected to drive the market.
- North America Sepsis Diagnostics Market Method Outlook (Revenue, USD Million , 2021-2033)
- Automated Diagnostics
- Conventional Diagnostics
- North America Sepsis Diagnostics Market Technology Outlook (Revenue, USD Million , 2021-2033)
- Immunoassays
- Others
- Microbiology
- Flow Cytometry
- Molecular Diagnostics
- North America Sepsis Diagnostics Market Pathogen Outlook (Revenue, USD Million , 2021-2033)
- Bacterial Sepsis
- Fungal Sepsis
- Viral Sepsis and Others
- North America Sepsis Diagnostics Market Testing Type Outlook (Revenue, USD Million , 2021-2033)
- Laboratory Testing
- Point-of-Care Testing
- North America Sepsis Diagnostics Market End User Outlook (Revenue, USD Million , 2021-2033)
- Hospitals & Clinics
- Pathology & Reference Laboratories
- Research Institutes and Others
- North America Sepsis Diagnostics Market Product Outlook (Revenue, USD Million , 2021-2033)
- Instruments
- Blood Culture Media
- Assay Kits & Reagents
- Software
Reasons to subscribe to Sepsis Diagnostics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Sepsis Diagnostics Market Outlook databook
- Our clientele includes a mix of Sepsis Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America Sepsis Diagnostics Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into North America Sepsis Diagnostics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
North America Sepsis Diagnostics Market, 2021-2033 (US$M)
North America sepsis diagnostics market statistics, by method, 2021-2033 (US$M)
